Evotec SE (ETR:EVT - Get Free Report) fell 4.1% during trading on Friday . The company traded as low as €6.57 ($7.55) and last traded at €6.57 ($7.55). 499,686 shares were traded during mid-day trading, a decline of 63% from the average session volume of 1,360,000 shares. The stock had previously closed at €6.85 ($7.87).
Evotec Stock Performance
The firm has a market capitalization of $1.21 billion, a P/E ratio of -7.08, a PEG ratio of 0.98 and a beta of 1.05. The firm has a 50 day simple moving average of €7.06 and a two-hundred day simple moving average of €7.47.
Evotec Company Profile
(
Get Free Report)
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health.
Featured Articles
Before you consider Evotec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evotec wasn't on the list.
While Evotec currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
